 |
 | |
 |  |
| We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level. |
Business Summary for FLMLY. Flamel Technologies S.A. is a drug delivery company engaged in the development and commercialization of controlled-release therapeutic products based on its proprietary polymer-based technology. For the fiscal year ended 12/31/98, revenues rose 18% to $9.5 million. Net loss rose 14% to $7.8 million. Revenues reflect the increased research payments from the Company's various partners. Higher loss reflects costs of the Venissieux pilot plant. Recent Earnings Announcement For the 3 months ended 03/31/1999, revenues were 1,298; after tax earnings were -2,877. (Preliminary; reported in thousands of dollars.) Price and Volume (updated Dec 9, 1999) 52-Week Low $1.00 Recent Price $2.625 52-Week High $4.875 Beta 1.10 Daily Volume (3-month avg) 39.3K Share-Related Items Market Capitalization $34.0M Shares Outstanding 12.9M Float 4.40M Tom B. | ||||||||||||||
|
| Home | Hot | SubjectMarks | PeopleMarks | Keepers | Settings |
| Terms Of Use | Contact Us | Copyright/IP Policy | Privacy Policy | About Us | FAQ | Advertise on SI |
| © 2026 Knight Sac Media. Data provided by Twelve Data, Alpha Vantage, and CityFALCON News |